Dear Sir,Please find Certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018 for the Quarter ended on December 31, 2025.
Omkar Pharmachem Ltd. Press Release Jan 10 2026
Filed with BSE ·
6ix hasn’t read this filing yet.
Earlier from Omkar Pharmachem
- Omkar Pharmachem Ltd. Press Release Jan 07 2026
- Announcement Under Regulation 30- Update- Re-Lodgment Of Transfer Of Shares Request Report For The Month Of December 2025
- Omkar Pharmachem Ltd. Press Release Dec 29 2025
- Closure of Trading Window
- Results- Unaudited Financial Results For September, 2025
Later from Omkar Pharmachem
- Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Change In Composition Of Committees Of The Board And Change In Name Of Company Secretary And Compliance Officer Of The Company.
- Omkar Pharmachem Ltd. Press Release Jan 27 2026
- Board Meeting Intimation for Board Meeting Intimation For Board Meeting Intimation For Inter-Alia, To Consider, Approve And Take On Record The Unaudited Standalone Financial Results Of The Company For The Quarter And Nine Months Ended On 31.12.2025
- Omkar Pharmachem Ltd. Press Release Feb 04 2026
- Omkar Pharmachem Ltd. Press Release Feb 12 2026
Follow Omkar Pharmachem into a list and get an email when it puts out news.
Follow Omkar Pharmachem